However, Hsieh et al. showed that canagliflozin can be also effective in lung squamous cell carcinomas, which do not express SGLT2 [16], confirming that a systemic effect of SGLT2is also plays a role in their anti-cancer effect (Figure 3). This evidence concerns the gene SLC5A2 and squamous cell lung carcinoma.